Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Los efectos del ejercicio agudo y crónico en el fenotipo inmunológico de los pacientes con leucemia linfocítica crónica

11 de noviembre de 2026 actualizado por: Mayo Clinic

This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune characteristics and function (phenotype) of patients with indolent non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers. Increasing CLL patients overall physical fitness levels, through exercise during the observation stage, may provide a realistic approach means to increase survival, decrease treatment-related side effects, and improve immune function. Information learned from this study may help researchers determine whether a particular exercise regimen can be used to strengthen the immune system of indolent NHL and CLL patients, delay time to disease progression, assess the need for treatment, and assess infection rates.

Descripción general del estudio

Descripción detallada

PRIMARY OBJECTIVES:

I. Determine how circulating immune cell abundance and function (via cell counts & cytokine profile) of CLL patients respond to acute (single bout) maximal exercise and how this differs from the response observed in group of age-matched controls by monitoring cardiopulmonary parameters and mobilization of immune cell phenotypes.

II. Determine how circulating immune cell mobilization and function (cell counts & cytokine profile) of CLL patients respond to a 12-week semi-supervised training program of moderate to high intensity, aerobic based exercise.

III. Evaluate the effectiveness of 12-weeks of semi-supervised exercise training (ET) versus (vs.) usual care (UC) at reducing cancer-related side effects and improving quality of life (QOL) and physical fitness in individuals with indolent non-Hodgkin (NHL) lymphoma during or after treatment.

IV. Determine that extent to which 12-weeks of semi-supervised ET can modify circulating immune cell mobilization and immune function in individuals with indolent NHL during or after treatment compared to UC.

V. Development of a forward-chaining AI expert system using both manual and physiology derived feedback to optimize training results and compare its efficacy at reducing cancer-related side effects and improving quality of life (QOL) and physical fitness in individuals with indolent NHL and CLL to that of the semi-supervised ET.

OUTLINE: CLL patients and healthy participants are assigned to Aim 1. CLL patients who complete all Aim 1 activities are assigned to Aim 2. Patients with indolent NHL will be assigned to Aims 3 and 4.

AIM 1: Participants undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (cardiopulmonary exercise testing [CPET]), and undergo collection of blood samples on study. Participants may also undergo dual X-ray absorptiometry (DEXA) scan on study.

AIM 2: CLL patients complete aerobic based training program on study. Patients then complete all Aim 1 activities again after completion of aerobic based training program.

AIMS 3-4: Indolent NHL patients undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study. Patients undergo muscular strength and functional endurance measurements of hand grip strength, upper body power via weighted chest pass, and leg strength with the timed chair stand test and 6-minute walk test (6MWT). Patients are then randomized to 1 of 2 arms.

ARM I: Patients receive usual care on study.

ARM II: Patients complete aerobic based training program on study. Patients then complete all baseline activities again after completion of aerobic based training program.

AIM 5: All patients from Aims 3-4 will be invited to repeat Aims 3-4 baseline activities.

After completion of study intervention, patients are followed up every 6 months (Aims 2-4) or annually (Aim 5) for 3 years.

Tipo de estudio

Intervencionista

Inscripción (Actual)

65

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Arizona
      • Scottsdale, Arizona, Estados Unidos, 85259
        • Mayo Clinic in Arizona
    • Minnesota
      • Rochester, Minnesota, Estados Unidos, 55905
        • Mayo Clinic in Rochester

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 80 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • English speaking
  • Between the ages of 18-80
  • Histologically confirmed diagnosis of indolent non-Hodgkin lymphoma (NHL) will be required to participate in Aim 2 (CLL/SLL only), aim 3 and 4 (indolent NHL) and aim 5 (indolent NHL) of this study

Exclusion Criteria:

  • Healthy subjects participating in Aim 1 will be excluded if they have known cardiovascular or pulmonary disease (e.g. heart disease, coronary artery disease, chronic obstructive pulmonary disease [COPD], asthma, etc.) an orthopedic or musculoskeletal limitation which would limit ability to exercise or are a current or former smoker
  • Indolent NHL individuals receiving treatment must have least 8 weeks of planned treatment remaining and those who have already received treatment must be at least 6 months post and have no planned treatments during the 12-week intervention period to be eligible. Individuals that are participating prior to receiving treatment must not have any scheduled treatments during their participation. Individuals will be excluded if they have uncontrolled hypertension, cardiac illness, or are not approved by their oncologist to participate

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación Secuencial
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Aim 1 (vitals, spirometry, CPET, blood samples, DEXA)

Participants undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study.

Ancillary studies

Undergo collection of blood

Otros nombres:
  • Recolección de muestras biológicas
  • Muestra biológica recolectada
  • Coleccion de especimenes

Ancillary studies

Undergo CPET

Otros nombres:
  • CPET
  • CPX

Undergo DEXA scan

Otros nombres:
  • DEXA
  • DXA
  • Escaneo de DMO
  • exploración de la densidad mineral ósea
  • Escaneo DEXA
  • exploración absorciométrica de rayos X de energía dual
  • Absorciometría dual de rayos X
  • Absorptometría dual de rayos X
  • ESCANEO DXA
  • DEXA (densidad ósea)

Undergo measurement of height/weight and vital signs

Otros nombres:
  • Evaluación
  • Examen general
  • Físico
  • Evaluación fisica
  • Examen físico
  • examen físico
  • Procedimiento de examen físico (procedimiento)

Undergo spirometry

Experimental: Aim 2 (aerobic based training program, Aim 1 activities)

CLL patients complete aerobic based training program on study. Patients then complete all Aim 1 activities again after completion of aerobic based training program.

Ancillary studies

Undergo collection of blood

Otros nombres:
  • Recolección de muestras biológicas
  • Muestra biológica recolectada
  • Coleccion de especimenes

Ancillary studies

Undergo CPET

Otros nombres:
  • CPET
  • CPX

Undergo DEXA scan

Otros nombres:
  • DEXA
  • DXA
  • Escaneo de DMO
  • exploración de la densidad mineral ósea
  • Escaneo DEXA
  • exploración absorciométrica de rayos X de energía dual
  • Absorciometría dual de rayos X
  • Absorptometría dual de rayos X
  • ESCANEO DXA
  • DEXA (densidad ósea)

Undergo measurement of height/weight and vital signs

Otros nombres:
  • Evaluación
  • Examen general
  • Físico
  • Evaluación fisica
  • Examen físico
  • examen físico
  • Procedimiento de examen físico (procedimiento)

Undergo spirometry

Undergo aerobic based training program

Comparador activo: Aims 3-4 arm I (indolent NHL usual care)

Indolent NHL patients undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study. Patients undergo muscular strength and functional endurance measurements of hand grip strength, upper body power via weighted chest pass, and leg strength with the timed chair stand test and 6MWT. Patients receive usual care on study.

Ancillary studies

Undergo collection of blood

Otros nombres:
  • Recolección de muestras biológicas
  • Muestra biológica recolectada
  • Coleccion de especimenes

Ancillary studies

Receive usual care

Otros nombres:
  • estándar de cuidado
  • terapia estándar

Undergo CPET

Otros nombres:
  • CPET
  • CPX

Undergo DEXA scan

Otros nombres:
  • DEXA
  • DXA
  • Escaneo de DMO
  • exploración de la densidad mineral ósea
  • Escaneo DEXA
  • exploración absorciométrica de rayos X de energía dual
  • Absorciometría dual de rayos X
  • Absorptometría dual de rayos X
  • ESCANEO DXA
  • DEXA (densidad ósea)

Undergo measurement of height/weight and vital signs

Otros nombres:
  • Evaluación
  • Examen general
  • Físico
  • Evaluación fisica
  • Examen físico
  • examen físico
  • Procedimiento de examen físico (procedimiento)

Undergo spirometry

Undergo muscular strength and functional endurance measurements

Otros nombres:
  • Pruebas de condición física
  • Pruebas de función física
Comparador activo: Aims 3-4 arm II (indolent NHL aerobic based training program)

Indolent NHL patients undergo measurement of height/weight and vital signs (blood pressure, temperature, heart and breathing rate), complete lung function testing (spirometry), undergo an exercise test (CPET), and undergo collection of blood samples on study. Participants may also undergo DEXA scan on study. Patients undergo muscular strength and functional endurance measurements of hand grip strength, upper body power via weighted chest pass, and leg strength with the timed chair stand test and 6MWT. Patients complete aerobic based training program on study. Patients then complete all baseline activities again after completion of aerobic based training program.

Ancillary studies

Undergo collection of blood

Otros nombres:
  • Recolección de muestras biológicas
  • Muestra biológica recolectada
  • Coleccion de especimenes

Ancillary studies

Receive usual care

Otros nombres:
  • estándar de cuidado
  • terapia estándar

Undergo CPET

Otros nombres:
  • CPET
  • CPX

Undergo DEXA scan

Otros nombres:
  • DEXA
  • DXA
  • Escaneo de DMO
  • exploración de la densidad mineral ósea
  • Escaneo DEXA
  • exploración absorciométrica de rayos X de energía dual
  • Absorciometría dual de rayos X
  • Absorptometría dual de rayos X
  • ESCANEO DXA
  • DEXA (densidad ósea)

Undergo measurement of height/weight and vital signs

Otros nombres:
  • Evaluación
  • Examen general
  • Físico
  • Evaluación fisica
  • Examen físico
  • examen físico
  • Procedimiento de examen físico (procedimiento)

Undergo spirometry

Undergo aerobic based training program

Undergo muscular strength and functional endurance measurements

Otros nombres:
  • Pruebas de condición física
  • Pruebas de función física
Experimental: Aim 5 (repeat baseline activities)

All patients from Aims 3-4 will be invited to repeat Aims 3-4 baseline activities.

Ancillary studies

Undergo collection of blood

Otros nombres:
  • Recolección de muestras biológicas
  • Muestra biológica recolectada
  • Coleccion de especimenes

Ancillary studies

Undergo CPET

Otros nombres:
  • CPET
  • CPX

Undergo DEXA scan

Otros nombres:
  • DEXA
  • DXA
  • Escaneo de DMO
  • exploración de la densidad mineral ósea
  • Escaneo DEXA
  • exploración absorciométrica de rayos X de energía dual
  • Absorciometría dual de rayos X
  • Absorptometría dual de rayos X
  • ESCANEO DXA
  • DEXA (densidad ósea)

Undergo measurement of height/weight and vital signs

Otros nombres:
  • Evaluación
  • Examen general
  • Físico
  • Evaluación fisica
  • Examen físico
  • examen físico
  • Procedimiento de examen físico (procedimiento)

Undergo spirometry

Undergo muscular strength and functional endurance measurements

Otros nombres:
  • Pruebas de condición física
  • Pruebas de función física

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Assess circulating immune cell abundance and function pre-intervention
Periodo de tiempo: Baseline

A standardized questionnaire will be administered to assess levels of past and current physical activity. Baseline measurement of pulmonary function (PFT) will be collected and possibly a body composition scan via dual x-ray absorptiometry (DEXA). While subjects perform cardiopulmonary exercise testing (CPET), cardiopulmonary vitals will be assessed and monitored throughout exercise and in recovery. A 40 mL venous blood sample will be drawn at baseline and post exercise (80 mL total), along with finger prick measures of blood lactate at rest and early recovery. Blood samples will be evaluated to determine how circulating immune cell abundance and function (via cell counts & cytokine profile) of chronic lymphocytic leukemia (CLL) patients respond to acute (single bout) maximal exercise and how this differs from the response observed in group of age-matched controls by monitoring cardiopulmonary parameters and mobilization of immune cell phenotypes.

Baseline
Assess circulating immune cell mobilization and function post-intervention
Periodo de tiempo: 12 weeks (at end of 12-week intervention)

Each subject will participate in a 12-weeks exercise program (3 times per week) at a moderate to high exercise intensity level based upon the results of their cardiopulmonary exercise testing (CPET). Upon completion of the program, subjects will return to the laboratory for post testing using the same techniques as used during the baseline. Venous blood samples drawn at rest after the program will be used to determine how circulating immune cell mobilization and function (cell counts and cytokine profile) of CLL patients respond to intervention. Usual descriptive statistics will be performed - means, standard deviations, and ranges. Comparisons within a group over time or pre/post will be performed using paired t-tests, while comparisons between groups will be performed using unpaired t-tests or where necessary using ANOVA. Comparisons will be made based on absolute values as well as changes during a test.

12 weeks (at end of 12-week intervention)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Assess circulating immune cell mobilization and function in follow-up
Periodo de tiempo: Annually up to 3 years

Each subject will participate in a 12-weeks exercise program (3 times per week) at a moderate to high exercise intensity level based upon the results of their cardiopulmonary exercise testing (CPET). Upon completion of the program, subjects will return to the laboratory for post testing using the same techniques as used during the baseline. Venous blood samples drawn at rest after the program will be used to determine how circulating immune cell mobilization and function (cell counts and cytokine profile) of CLL patients respond to intervention. Usual descriptive statistics will be performed - means, standard deviations, and ranges. Comparisons within a group over time or pre/post will be performed using paired t-tests, while comparisons between groups will be performed using unpaired t-tests or where necessary using ANOVA. Comparisons will be made based on absolute values as well as changes during a test.

Annually up to 3 years
Fatigue - SCFS (indolent NHL only)
Periodo de tiempo: Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years

The Schwartz Cancer Fatigue Scale (SCFS) is a 6-item instrument measuring physical and perceptual dimensions of fatigue experienced over the past 2 to 3 days. Each item is scored on a 5-point scale from 1 (not at all) to 5 (extremely) with scores ranging from 6 to 36. Higher scores indicate greater perception of fatigue.

Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years
Fatigue - FACIT-F (indolent NHL only)
Periodo de tiempo: Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years

The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) is a 13-item questionnaire used to measure fatigue levels and impact of fatigue on daily activities over the past 7 days. Each item is scored on a 5-point scale from 0 (not at all) to 4 (very much). total scores range from 0 to 52 with higher scores indicating lower level of fatigue.

Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years
Quality of Life - EORTC-QLQ-C30 (indolent NHL only)
Periodo de tiempo: Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years

The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ)-C30 is a 30-item questionnaire a questionnaire used to assess the quality of life of cancer patients. Twenty-eight questions are answered on a scale of 1-4 (1=not at all, 2=a little, 3=quite a bit, and 4= very much), and two questions are answered on a scale of 1-7 (1= very poor and 7=excellent). Higher summary scores indicate better health related quality of life.

Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years
Physical Activity - GPAQ (indolent NHL only)
Periodo de tiempo: Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years

The Global Physical Activity Questionnaire (GPAQ) is a 16-item survey used to measure physical activity levels and sedentary behavior over the past week. Participants record different types and duration of physical activity in a typical week. Overall responses is scored by calculating Metabolic Equivalent of Task (MET) minutes and classifying physical activity levels as low, moderate, or high based on World Health Organization (WHO) guidelines.

Baseline; 12 weeks (at end of 12-week intervention); every 6 months up to 3 years

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Michael P. Gustafson, PhD, Mayo Clinic

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

12 de junio de 2023

Finalización primaria (Actual)

18 de septiembre de 2025

Finalización del estudio (Estimado)

18 de septiembre de 2029

Fechas de registro del estudio

Enviado por primera vez

1 de mayo de 2023

Primero enviado que cumplió con los criterios de control de calidad

16 de mayo de 2023

Publicado por primera vez (Actual)

26 de mayo de 2023

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

11 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 22-012246
  • 22-012246 (Otro identificador: Mayo Clinic Institutional Review Board)
  • NCI-2023-03210 (Identificador de registro: CTRP (Clinical Trial Reporting Program))

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir